(1 - 5 von 6
)
Boehringer Ingelheim: Empagliflozin reduced the risk of ...www.finanznachrichten.de › nachrichten
www.finanznachrichten.de
About EMPRISE · About Cardio-Renal-Metabolic Conditions · About Heart Failure · About Empagliflozin · Fabian Agel · Greg Kueterman
Empagliflozin reduced the risk of cardiovascular events and ...aetoswire.com › news › empagliflozin-reduced-the-r...
aetoswire.com
· Fabian Agel Product Communication Manager Boehringer Ingelheim . Phone: +49 (6132)
sortiert nach Relevanz / Datum